28 TH ANNUAL MEETING
and E D U C AT I O N DAY
OF THE SOCIETY
FOR NEURO-ONCOLOGY

November 15-19, 2023
Vancouver Convention Centre

Vancouver, Canada

MEETING PROGRAM
SOC-NEURO-ONC.ORG

Discover the
power and efficacy
of Optune Gio™
VISIT BOOTH #313
For each person who plays the arcade game at our booth,
Novocure® will make a charitable donation.

Learn more at OptuneGioHCP.com

Optune Gio is not available for sale in Canada.
TTFields therapy is available as a treatment in Canada under the name Optune®.

©2023 Novocure GmbH. All Rights Reserved. Optune Gio and Novocure are trademarks of Novocure GmbH. GLB-OPG-00008 v1.0 October 2023

TA B L E O F C O N T E N T S
Welcome Letter and Scientific Committee			4

Meeting Overview					

6CME Information					

8SNO Leadership, Award Recipients and Supporters

12

Education Day Program					

18Main Meeting Program				- Friday							

19- Saturday						

22- Sunday						

25Ancillary and Committee Meetings			

26

Special Events, Lunch and Dinner Sessions		

27

Independent Supported Sessions				

30

Exhibitors						

32Meeting Room Maps					

3528TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 3

WELCOME TO VANCOUVER!
Dear Colleagues,
We are pleased to welcome you to the eclectic and vibrant city of Vancouver, British Columbia, Canada, forthe 28th Annual Meeting of the Society for Neuro-Oncology!
The SNO Annual Meeting is the world’s largest neuro-oncology conference, regularly attracting over
2600 researchers and clinician scientists from over 40 countries. Spanning all neuro-oncology disciplines,
professions, and interests, the 2023 SNO Annual Meeting will be the premier forum at which to shareknowledge and gain insights on the future of neuro-oncology research and treatment.

Shawn L. Hervey-Jumper

The theme of this year’s meeting is Neuro-Oncology at the Intersections: Multidisciplinary Approaches to
Improve Patient Outcomes, and as you will see in the program, we are fortunate to have a broad range ofoutstanding educational sessions spanning the breadth of our field.
We also hope you will find some time to enjoy the city of Vancouver -- a haven for outdoor enthusiasts andcosmopolitan adventurers alike. Vancouver is known for its enviable mix of laid-back West Coast living andstriking skyline, with snow-capped coastal mountains in the distance.
Against this backdrop, we believe this year’s SNO Annual Meeting will provide an outstanding opportunity
for networking and building lasting relationships with like-minded colleagues from around the world.

Michelle Monje

We hope you enjoy the meeting!
Sincerely,
Scientific Meeting Co-Chairs

4 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Humsa Venkatesh

2023 Scientific Committee
Scientific Meeting Chairs
Shawn Hervey-Jumper
Michelle Monje
Humsa Venkatesh

Education Day
Applied Science
Alicia Gomes
Rimas Lukas
Nicole Ullrich

Education Day
Basic Science
Othon Iliopoulos
Russell Lonser

Neuro-Oncology
Review Course
Sadhana Jackson
Katherine Peters
Jennie Taylor

Neuro-Oncology Fellow
and Early Career Retreat
Anna Janss
Edjah Nduom
Scott PlotkinSpecial Interest Tracks

CNS Rare Tumors

Neurosurgery

Track Leadership

Ugo Chukwueke
Marta Penas-Prado

Lissa Baird
William Curry
Viviane Tabar

Priscilla Brastianos
Albert Kim
Farshad Nassiri

Basic Science
Suzanne Baker
Erin Gibson
Samuel McBrayer

Brain Metastases
Priya Kumthekar
Alexandra Zimmer

Cancer Neuroscience
Benjamin Deneen
Eudocia Lee
Maciej Mrugala

Clinical Trials
Stephen Bagley
Maryam Fouladi
Karisa Schreck

Molecular Pathology
Cynthia Hawkins
MacLean Nasrallah
Joanna Phillips

Neurogenetic Tumor
Syndromes

Pediatrics
Eugene Hwang
Ashley Margol
Sabine Mueller

Radiation Sciences

Jaishri Blakeley
Brigitte WidemannDavid RaleighDebra Yeboa

Neurohematology

Survivorship

Oussama Abla
Christian Grommes
Lakshmi Nayak

Nancy Ann Oberheim Bush
Lisa Kahalley
Heather Leeper

Neuroimaging
Ramon Barajas
Elizabeth Gerstner
Tina Young

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 5

MEETING OVERVIEWThe SNO Annual Meeting will take place live and in-person at the beautiful
Vancouver Convention Centre in Vancouver, British Columbia, Canada. As
British Columbia’s largest city, Vancouver is a haven for outdoor enthusiasts
and cosmopolitan adventurers alike. Vancouver is known for its enviable mixof laid-back West Coast living and striking skyline, with the snow-capped
coastal mountains as a picturesque backdrop.

Registration Hours
Registration will take place in the Exhibit Hall Foyer of the Vancouver
Convention Center during the following hours:•
Wednesday, November 15, 4:00pm - 7:00pm•
Thursday, November 16, 7:00am - 5:00pm•
Friday, November 17, 6:30am - 6:00pm•
Saturday, November 18, 6:30am - 4:00pm•
Sunday, November 19, 8:00am - 10:30am

Speaker Resource Room
All oral presenters are asked to drop off their slides in the Speaker Resource
Room located in Rooms 105-106 if they did not previously upload them via theweb. Check your email for presentation requirements.
Speaker Resource Room Hours:•
Wednesday, November 15, 6:00am - 6:00pm•
Thursday, November 16, 7:00am - 6:00pm•
Friday, November 17, 6:30am - 6:00pm•
Saturday, November 18, 6:30am - 6:00pm•
Sunday, November 19, 8:00am - 11:00am

Exhibition Hours••••

Thursday, November 16, 7:00am - 5:30pm
Friday, November 17, 7:00am - 9:30pm
Saturday, November 18, 7:00am - 5:00pm
Sunday, November 19, 8:00am - 11:45pm

Coffee and Boxed Lunches
Morning and afternoon coffee breaks will be provided. Pre-paid boxed lunches
will be available for pickup. If you did not pre-pay for lunch, the same boxedlunch will be available for purchase at the concession stand in Exhibit Hall A/Bfrom 12:15-2:00 pm.

Internet Access
Wi-Fi, supported by Chimerix, Inc., is available in the main conference rooms
and foyer areas.
Network name: SNOConference
Password: sno_2023
Charging stations for mobile devices can be found in Exhibit Hall
A/B, supported by Alexion Pharmaceutics, Novartis, and Day One
Biopharmaceuticals.

Tai Chi Sunrise and Lunch Sessions
Join us for Tai Chi and Qigong exercises Thursday-Saturday in Room 302 torefresh and re-center yourself. Sunrise sessions begin at 6:00am, and lunch
sessions start at 12:15pm on Thursday and 11:30am on Friday. Let’s find yourchi at SNO!

Nursing Mothers
SNO has designated Showroom B in Exhibit Hall A/B for nursing mothers.
Please see Megan Bell-Johnston in the exhibit hall for a key during the event.

6 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

SNO Meeting APP

SNO Gala

Download the official SNO meeting app, supported by Novocure, and put
everything you need to know about this year’s conference right into thepalm of your hand! The app lets you customize your schedule in advance,
communicate with attendees through the attendee directory, view oral andposter scientific abstracts, text questions to moderators, and take session
notes. The SNO meeting app is currently available in the App Store andAndroid Market. To download, simply search for “SNO Scientific Meetings”
and then select the event SNO2023. To start using the SNO2023 event app,please sign-in using the same username and password that was used toregister for the conference to access the mobile app.

Come get “SNO-ed” In at the SNO Annual Gala that will take place at theCommodore Ballroom, a music venue modeled after a 1920 British Ballroom.
Join us for a frosty event and enjoy live music, dancing, local food, a SNOinspired cocktail, and more. You don’t want to miss this truly memorable
event. Pre-purchased ticket required.

Welcome Reception
Join your friends and colleagues to kick off the 2023 SNO Annual Meetingat the “Welcome to Vancouver” reception. Stroll through the different
neighborhoods of Vancouver and experience the rich cultural heritage whilesampling food and drinks along your way. The Welcome Reception is open to
all members.

SNO Central
Be sure to stop by “SNO Central” in the exhibit hall! At SNO Central, you
can get information on SNO membership, the Neuro-Oncology Academy,
and SNO’s new membership platform, SNO Central. You’ll also have theopportunity to interact with representatives from Oxford University Press, the
SNO Wellness Committee, and the Central Brain Tumor Registry of the UnitedStates.

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 7

CONTINUING MEDICAL EDUCATION (CME)EDUCATION DAY
of the Society for Neuro-Oncology
November 16, 2023

Educational Objectives••••

This activity is supported by an educational grant from
SpringWorks.

•

Describe the mechanism of disease and the biology of the tumor
microenvironment of the tuberous sclerosis complex.
Identify clinical diagnostic techniques and therapies used in thetreatment of patients with tuberous sclerosis.
Describe the mechanism of disease and the biology of the tumor
microenvironment of neurofibromatosis type 1 and neurofibromatosis
type 2 related schwannnomatosis.
Compare and contrast diagnostic criteria and treatment modalities usedin managing the care of patients with neurofibromatosis type 1 andneurofibromatosis type 2 related schwannomatosis.
Describe the mechanism of disease and the biology of the tumor
microenvironment of von Hippel-Lindau disease.
Identify genetic variations, screening approaches and therapeutic
management of patients with von Hippel-Lindau disease.
Summarize genetic testing requirements, genetic counseling needs andthe clinical implications of genetic testing and counseling associated withthe care of patients with tuberous sclerosis, neurofibromatosis and vonHippel-Lindau disease.

Target Audience•

Neuro-oncologists (both neurology and medical oncology-trained), Medical
Oncologists, Neurosurgeons, Neuro-radiologists, Neuropathologists,
Neuropsychologists, Radiation Oncologists, Basic and Translational Scientists,
Basic and Clinical Science Trainees, Allied Health Professionals, Palliative Care
Professionals, Industry Professionals, Regulatory and Government Officials,
Patient Advocates, and Nursing Professionals.

•

Statement of Need/Program Overview

The Society for Neuro-Oncology is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.

As an adjunct to the 2023 SNO Annual Meeting, the Education Day on
November 16 will feature specialized content focusing on Nervous System
Tumor Susceptibility Syndromes: Neurofibromatosis, Tuberous Sclerosis, vonHippel Lindau and related syndromes. There will be two distinct tracks on thistheme, one addressing basic science and the other addressing the appliedand practical aspects of managing the care of patients with these challenging
syndromes.

Physician Accreditation Statement

Physician Credit Designation
The Society for Neuro-Oncology designates this live activity for a maximum of
6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.

8 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

SNO Contact Information

Deadline to claim CE Credit is Monday, February 12, 2024.

continuing education credits are awarded must bebalanced, independent, objective, and scientificallyrigorous. All persons in a position to control thecontent of accredited continuing education program
are required to disclose all financial relationships withany ineligible company within the past 24 months .
All financial relationships reported are identified as
relevant and mitigated by Society for Neuro-Oncology
in accordance with the Standards for Integrity andIndependence in Accredited Continuing Education in advance of deliveryof the activity to learners. The content of this activity has been vetted toassure objectivity and that the activity is free of commercial bias. All relevant
financial relationships have been mitigated by SNO.

Refund/Cancellation Policy

Disclosure of Unlabeled Use

For more information about the accreditation of this program, please contact
the Society for Neuro-Oncology CME Program Manager, MeLesa Ritterhouse,
RN at melesa@soc-neuro-onc.org.

Instructions to Receive Credit
In order to receive credit for this activity, the participant must have attended
the sessions in-person (you cannot claim CME for on-demand sessions),
complete the overall program evaluation and session evaluations by logging
in to this website by using the QR code or the conference mobile app by using
the users registration login.

The deadline for cancellations with refund is Thursday, November 2, 2023.
Cancellations must be received in writing and a $50 cancellation fee will beassessed. Cancellations received after the deadline date cannot be refunded,
but the meeting registration can be transferred to another person withwritten authorization.
Please note that your SNO membership must be current if you have chosen
to register as a SNO member. SNO reserves the right to confirm that you haveregistered in the correct category.

This educational activity may contain discussion of published and/or
investigational uses of agents that are not indicated by the FDA. The Society
for Neuro-Oncology does not recommend the use of any agent outside of thelabeled indications.
The opinions expressed in the educational activity are those of the faculty anddo not necessarily represent the views of any organization associated with thisactivity. Please refer to the official prescribing information for each product for
discussion of approved indications, contraindications, and warnings.

Payment must be received in full before access to the meeting can be granted.

Disclaimer

Email all cancellation and transfer requests to Program Registrar Caroline
Noor, caroline@soc-neuro-onc.org.

Participants have an implied responsibility to use the newly acquired information
to enhance patient outcomes and their own professional development. The
information presented in this activity is not meant to serve as a guideline
for patient management. Any procedures, medications, or other courses ofdiagnosis or treatment discussed in this activity should not be used by clinicians
without evaluation of patient conditions and possible contraindications on
dangers in use, review of any applicable manufacturer’s product information,and comparison with recommendations of other authorities.

Disclosure of Relevant Financial Relationships
The Society for Neuro-Oncology (SNO) adheres to the policies and guidelines,
including the Standards for Integrity and Independence in Accredited
Continuing Education, set forth to providers by the Accreditation Council
for Continuing Medical Education (ACCME), stating those activities where

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 9

CONTINUING MEDICAL EDUCATION (CME)
28TH ANNUAL MEETINGof the Society for Neuro-Oncology
November 17 - 19, 2023

This activity is a collaboration of researchers and clinicians disseminating new
knowledge to healthcare professionals in order to provide the highest qualityof patient care to improve patient outcomes. The goal is to provide healthcare
professionals with updated viewpoints, strategies, collaboration opportunities
and an increased knowledge base to maximize treatment and improveoutcomes for brain tumor patients.

Educational Objectives•
This activity is supported by an educational grant from
Merck, Novocure and Servier.

Target Audience
Neuro-oncologists (both neurology and medical oncology-trained), Medical
Oncologists, Neurosurgeons, Neuro-radiologists, Neuropathologists,
Neuropsychologists, Radiation Oncologists, Basic and Translational Scientists,
Basic and Clinical Science Trainees, Allied Health Professionals, Palliative Care
Professionals, Industry Professionals, Regulatory and Government Officials,
Patient Advocates, and Nursing Professionals.

•
•
•
•

Summarize the latest basic science discoveries in the field of neurooncology.
Discuss advances in multidisciplinary diagnosis and treatment of patientswith CNS malignancies.
Define advances and challenges in clinical trial design, delivery, andtreatment for patients with CNS malignancies.
Identify new advances in the multidisciplinary care of pediatric,
adolescent, and young adult patients with CNS malignancies.
Discuss how to use the advances of artificial intelligence and machinelearning models in the care of patients with CNS malignancies.

Statement of Need/Program Overview

Physician Accreditation Statement

The Society for Neuro-Oncology’s Annual Meeting is the largest and mostinfluential meeting for multidisciplinary collaboration in the field of NeuroOncology. The latest advances in Central Nervous System (CNS) cancers
are shared with an international audience that includes a variety of subspecialties involved in basic and translational research, clinical as well as
symptom management research. The meeting fosters opportunities to explore
collaborations that will positively influence outcomes for patients with CNS
cancers. This year’s meeting will highlight the theme of Neuro-Oncology at theIntersections: Multidisciplinary Approaches to Improve Patient Outcomes.

The Society for Neuro-Oncology is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical
education for physicians.

Physician Credit Designation
The Society for Neuro-Oncology designates this live activity for a maximum of
12.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.

10 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

SNO Contact Information

Deadline to claim CE Credit is Monday, February 12, 2024.

continuing education credits are awarded must bebalanced, independent, objective, and scientificallyrigorous. All persons in a position to control thecontent of accredited continuing education program
are required to disclose all financial relationships withany ineligible company within the past 24 months.
All financial relationships reported are identified as
relevant and mitigated by Society for Neuro-Oncology
in accordance with the Standards for Integrity andIndependence in Accredited Continuing Education in advance of delivery of
the activity to learners. The content of this activity has been vetted to assure
objectivity and that the activity is free of commercial bias. All relevant financial
relationships have been mitigated by SNO.

Refund/Cancellation Policy

Disclosure of Unlabeled Use

The deadline for cancellations with refund is Thursday, November 2, 2023.
Cancellations must be received in writing and a $50 cancellation fee will beassessed. Cancellations received after the deadline date cannot be refunded,
but the meeting registration can be transferred to another person with written
authorization.

This educational activity may contain discussion of published and/or
investigational uses of agents that are not indicated by the FDA. The Society
for Neuro-Oncology does not recommend the use of any agent outside of thelabeled indications.

Please note that your SNO membership must be current if you have chosen
to register as a SNO member. SNO reserves the right to confirm that you haveregistered in the correct category.

The opinions expressed in the educational activity are those of the faculty anddo not necessarily represent the views of any organization associated with thisactivity. Please refer to the official prescribing information for each product for
discussion of approved indications, contraindications, and warnings.

For more information about the accreditation of this program, please contact
the Society for Neuro-Oncology CME Program Manager, MeLesa Ritterhouse,
RN at melesa@soc-neuro-onc.org.

Instructions to Receive Credit
In order to receive credit for this activity, the participant must have attended
the sessions in-person (you cannot claim CME for on-demand sessions),
complete the overall program evaluation and session evaluations by logging
in to this website by using the QR code or the conference mobile app by using
the users registration login.

Payment must be received in full before access to the meeting can be granted.
Email all cancellation and transfer requests to Program Registrar Caroline
Noor, caroline@soc-neuro-onc.org.
  Disclosure of Relevant Financial Relationships

The Society for Neuro-Oncology (SNO) adheres to the policies and guidelines,
including the Standards for Integrity and Independence in Accredited
Continuing Education, set forth to providers by the Accreditation Council
for Continuing Medical Education (ACCME), stating those activities whereDisclaimer
Participants have an implied responsibility to use the newly acquired information
to enhance patient outcomes and their own professional development. The
information presented in this activity is not meant to serve as a guideline
for patient management. Any procedures, medications, or other courses ofdiagnosis or treatment discussed in this activity should not be used by clinicians
without evaluation of patient conditions and possible contraindications on
dangers in use, review of any applicable manufacturer’s product information,and comparison with recommendations of other authorities.

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 11

SNO Staff
Angie Ames

2023 SNO Leadership

Medical Education Support Specialist

Officers

Megan Bell-Johnston

Tracy Batchelor

Maloree Burgin

Daphne Haas-Kogan

Exhibits and Support Specialist
Event Support Specialist

Gabrielle Griffin

Marketing and Communications Specialist

Amelia Hutsell

Administrative Specialist

Olivia Ing

Medical Education Support Specialist

Kristina Knight

Manager of Medical Education

Carolyn Loch

Medical Education Support Specialist

Tara A. Mammoser

Manager of Medical Education

Caroline K. Noor

Manager, Member Services and Giving

Kristin Odom

Graphic Designer

Shelley Pressley

Director of Administration

MeLesa Ritterhouse
Manager of CME

Ginger Vazquez

Manager, Technology Integration

President

Vice President

Jill Barnholtz-Sloan

Mary Jane Lim Fat

Young Investigator Representative

Linda Bi

Neurosurgery Representative

Benjamin Ellingson

Radiology Representative

Secretary-Treasurer

Joanna Phillips

Charles (Chas) Haynes
Executive Director (ex officio)

Annie Huang

Board of Directors
Susan Chang

Journal Editor-in-Chief (ex officio)

Gelareh Zadeh

Immediate Past President

Mary Lou Affronti

Allied Health Representative

Eudocia Q. Lee

Neurology Representative

Pathology Representative
Pediatrics Representative

Erin Dunbar

Medical Oncology Representative

Joseph CostelloBasic Science Representative

Helen Shih

Radiation Oncology Representative

Quinn Ostrom

Other Specialties Representative

Abstract Reviewers
Ashley Aaroe		Roger Abounader		
Christina Amidei		Mark Anderson		Yoshiki Arakawa		
Isabel Arrillaga-Romany		
Michael Badruddoja		
Simon Bailey		
Spyridon Bakas		
Karla Ballman		Fred Barker		
Jill Barnholtz-Sloan		
Anna Berghoff		
Krishna Bhat		Orin Bloch		
Nicholas Blondin		
Adrienne Boire		Eric Bouffet		
Steve Braunstein		Joshua Breunig		
Rob Buerki		
Helen Bulbeck		
Severa Bunda		
Eric Burton		Nicholas Butowski		Daniel Cahill		Jennifer Cahilll		Jian Campian		
Steven Carroll		Ali Chahlavi		
Al Charest		
Zhihua Chen		
Shi-Yuan Cheng		Lawrence Cher		Sameul Cheshier		
Milan G. Chheda		
Olivier L. Chinot		
Elizabeth Claus		

Steven Clifford		Adam Cohen		
Howard Colman		
Joe Costello		
Sonika Dahiya		
Sunit Das		
Biplab Dasgupta		
John de Groot		Filip De Vos		Ana C. deCarvalho		
Annick Desjardins		
Frederic Dhermain		
Roberto Diaz		Aaron Diaz		
Jorg Dietrich		
Jan Drappatz		
Erin M. Dunbar		
Charles Eberhart		
Jeanette Eckel-Passow
David D. Eisenstat		Brad Elder		
Ben Ellingson		Anat Erdreich-Epstein		Yoshua Esquenazi		Arnold Etame		Peter Fecci		
Sherise Ferguson		
Mariella Filbin		
Jonathan Finlay		
Gaetano Finocchiaro		
Carolina Fittipaldi
PessôaEkokobe Fonkem		
Nicholas Foreman		
Deborah Forst		
Gregory Friedman		
Takamitsu Fujimaki		
Dan Fults		

Frank Furnari		
Amar Gajjar		Evanthia Galanis		
Norbert Galldiks		
Ashley Ghiaseddin		L. Nicolas Gonzalez
Castro		John Goodden		C. Rory Goodwin		
Jerome Graber		Daphne Haas-Kogan		Constantinos
Hadjipanayis		Rebecca Harrison		Peter Hau		
Ann-Christin Hau		
Monika Hegi		
Anita Hjelmeland		
Lindsey Hoffman		
Matthias Holdhoff		
Craig Horbinski		Adilia Hormigo		
Raymond Huang		
Cristiane Ida		
Bryan Iorgulescu		
Alok Jaju		
Asgeir Jakola		
Rakesh Jalali		
Robert Jenkins		
Michael D. Jenkinson		Derek Johnson		Sandra Johnston		Justin T. Jordan		
Tareq Juratli		
Saranya Kakumanu		
Seok-Gu Kang		Matthias Karajannis		
Timothy Kaufmann		Mustafa Khasraw		 Suely Melo		
Noriyuki Kijima		 Thomas Merchant		
Michelle Kim		 Ryan Miller		
Julie J. Miller		
Cassie Kline		
Takashi Komori		 Ana Misir Krpan		Paul Kongkham		 Annette Molinaro		
Carl Koschmann		 Giovanni Morana		Andra Krauze		 Akitake Mukasa		Frank A.E. Kruyt		 Erin S. Murphy		
Louis Nabors		
John Kuo		
Sandeep Kuril		 Motoo Nagane		
Matthew Ladra		 Seema Nagpal		
Katrin Lamszus		 Jean Nakamura		
Mioara Larion		 Yoko Nakasu		Andrew B. Lassman		 Josh Neman		
John Laterra		 Kathryn Nevel		
Sean E. Lawler		 William Newman		
Doug Ney		Ian Lee		Glenn Lesser		 Ryo Nishikawa		
Lindsay Lipinski		 Paul Northcott		James K. C. Liu		 Martha Nowosielski		
Mina Lobbous		 Nancy Ann Oberheim
Bush		
Philipp Lohmann		
Makoto Ohno		
Hernando Lopez-Bertoni		Hideho Okada		
Rimas Lukas		
Janine M. Lupo		 Andrea Pace		
Tobey MacDonald		 Michael W. Parsons		Anita Mahajan		 David Peereboom		Rachna Malani		 Yanxin Pei		
Marcos Maldaun		 Alessia Pellerino		
Aaron Mammoser		 Sébastien Perreault		
Jacob Mandel		 Claudia Petritsch		
Warren Mason		 Jennifer Philip		
ClaireMazewski		 David Piccioni		Braden C. McFarland		 David Plas		
Minesh Mehta		 Scott Pomeroy		Whitney Pope		
Isaac MelguizoMatthias Preusser		
Gavilanes		

Vinay Puduvalli		Prajwal Rajappa		Rohan Ramakrishna		Otto Rapalino		David Reardon		
Jeremy Rich		
Fausto Rodriguez		
Michael Rodriguez		
Lisa Rogers		
Federico Roncaroli		
Alasdair Rooney		
Patrick Roth		Jean-Francois Rual		Roberta Rudà		Solmaz Sahebjam		
Norihiko Saito		
Sussan Salas		Jann Sarkaria		
Hikaru Sasaki		Sith Sathornsumetee		
Lauren Schaff		
Adrienne Scheck		Michael Scheurer		David Schiff		Michael Schulder		
Bjoern Schwer		
Akanksha Sharma		Wendy Sherman		
Wenyin Shi		
Nicole Shonka		Joshua Silverman		
Tania Slatter		
James Snyder		
Riccardo Soffietti		
Erik Sulman		
Masamichi Takahashi		
Ruth Tatevossian		Jennie W. Taylor		

Brett Theeler		
Alissa Thomas		
Christopher Tinkle		
Joerg Tonn		Nam Tran		David D. Tran		Nicole Ullrich		
Yoshie Umemura		
Monica Venere		
Varun Venkataramani		
Javier Villanueva-Meyer		
Pavithra Viswanath		
Michael Vogelbaum		André von Bueren		
Derek Wainwright		
Tobias Walbert		
Kyle Walsh		
Kathy Warren		Shiao-Pei Weathers		
Jeffrey Wefel		Tobias Weiss		
Michael Weller		
Leonardo Augusto
Wendling Henriques		Frank Winkler		
Margaret Wrensch		Cheng-Chia Wu		Jing Wu		
Zhiyuan Xu		Jonathan Yang		
Kee Kiat Yeo		
Stephen Yip		
Raymund Yong		Robert Young		Jennifer Yu		Jay-jiguang Zhu

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 13

Award Recipients
Abstract Awards

Named Awards
Award						Lifetime Achievement Award				SNO Excellence in Education Award, Honoring Lisa DeAngelis
Jan Esenwein Public Service Award			The Victor Levin Award				

Recipient		
Lisa DeAngelis
Vinay K. Puduvalli
Tara Mammoser
Evanthia Galanis

Women in Neuro-Oncology (WiN) and Abstract Awards
Award						The WiN Mid-Career Exemplary Physician Award		
The WiN Mentorship Award				WiN Abstract Award in Basic/Translational Science Research
WiN Abstract Award in Clinical Research			

Meeting Session Monitors
Katrina Roberto
Kira Tosefsky
Alexandar Rebchuck
Karina Chornenka
John Paul
Josephine Volovetz

Elizabeth Summers
Naina Murthy
Leopoldo Alfredo Garcia
Montano Garcia
Yamhilette Licon Munoz

RecipientPriya Kumthekar
Jaishri O. Blakeley
Corina Anastasaki
Katherine Peters

Award					Excellence in Clinical Trials			
Excellence in Healthcare Equity			
Excellence in Neurosurgery			
Excellence in Basic Science			
Excellence in Pediatric				
Excellence in Neurohematology			
Excellence in Radiation			
Excellence in Cancer Neuroscience		
Excellence in Cancer Neuroscience		
Excellence in CNS Metastases			
Excellence in CNS Metastases			
Excellence in Neurology of Cancer		Excellence in Neurology of Cancer		Excellence in Survivorship			
Excellence in Basic Science			
Excellence in CNS Rare Disease			
Excellence in Neurogenetic Tumor Syndromes
Excellence in Molecular Pathology		
Excellence in Neuro-imaging			
EANO Abstract Scholarship Award		
EANO Abstract Scholarship Award		
Andrew Parsa Young Investigator Award		

14 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Recipient
Karsten Nysom
Orieta Celiku
Akhil Kondepudi
Karl Habashy
Evangeline R. Jackson
Lakshmi Nayak
William C. Chen
Richard Drexler
Vardhaan Ambati
Debarati Bhanja
Emma K. Rigg
Michel Friedrich
Francesco Bruno
Christina Weyer Jamora
Jenna K. Minami
Priscilla K. Brastianos
Scott R. Plotkin
Erik A. Williams
Jacob Ellison
Fulvio D’Angelo
Ashlee R. Loughan
Aparna Bhaduri

Scholarship Recipients
2023 SNO Women and Diversity Scholarship Recipients
Joshua Casaos
Laurence Dery
Julia Gomez
Cierra Harper
Alexis Hyatt
Jessica D. Johnson
Juliette Latulippe
Melinda Miculinich
Amen Okundaye

2023 SNO International Outreach Scholarship Recipients
Mohammed AFIF - Morocco
Chandrima Biswas - India
Ranhel C. De Roxas - Philippines
Leonardo Augusto Wendling Henriques - Brazil
Julia Hoveyan - Armenia
Maria Angelica Liza Imperial - Philippines
Supriya Mallick - India
Larrey Kasereka Kamabu - Democratic Republic of the Congo
Victoria Mwebe Katasi - Uganda
Khalif Abdifatah Mohamed - Kenya
Mba Adaeze Morna - Nigeria
Adhikari Sudhir - Nepal
Hulya Torun - Türkiye
Larissa Nubia Nunes Vilany - Brazil

Supporters
The Society for Neuro-Oncology gratefully acknowledges the SNO
supporters listed below. Their on-going support allows SNO to fulfill its
mission to advance neuro-oncology research and education.

Platinum Level

Supporter Level

American Brain Tumor Association
Chimerix
National Brain Tumor Society
Northwest Biotherapeutics
Novocure
Pediatric Brain Tumor Foundation
Servier
The Sontag Foundation

Day One Biopharmaceuticals
Imvax
Merck
Plus Therapeutics
SonALAsense
SpringWorks Therapeutics

Benefactor Level
Kazia Therapeutics
Orbus Therapeutics, Inc.

Contributer Level
Alexion Pharmaceutics
End Brain Cancer Initiative
Monteris Medical
Novartis

General Level
Gift From A Child

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 15

MEETING WIFINETWORK NAME: SNOConference
PASSWORD: sno_2023
Internet supported by Chimerix, Inc.

16 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

FOLLOW US@NEUROONC #SNO2023
Follow our Featured Voicesof the 2023 SNO Annual Meeting
Tina Skinner @tinaBTSupport
Katherine Onk @Kate_chain
Kristin Swanson @gliomathAdam Hayden @adamhayden
Maximillion Deng @maxiydeng1994
Ranjit Bindra @ranjitbindra
James Perry @gliomadoc
Mustafa Khasraw @mkhasraw

Justin Lathia @JustinLathia
Jennie Taylor @JennieWTaylor
Wolfgang Wick @wick_wolfgang
Albert Kim @AlbertHKimMDPhD
Michelle Monje Deisseroth @michelle_monje
Shawn Hervey-Jumper @HerveyJumper
Monica Venere @VenereLabOSU
Maciej Mrugala @MrugalaMaciej
28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 17

Thursday, November 16, 2023 EDUCATION DAY
BASIC SCIENCE Co-Chairs: Othon Iliopoulos, Russell Lonser

APPLIED SCIENCE Co-Chairs: Alicia Gomes, Rimas Lukas, Nicole Ullrich

Exhibit Hall C

Ballroom A

8:00-9:40am		

MORNING SESSION
Session I: Tuberous Sclerosis

8:00-10:00am		

MORNING SESSION
Session I: Neurofibromatosis

8:10-8:40am
		Keynote Lecture: Tuberous Sclerosis and Metobolic
Reprogramming - Brendan D. Manning

8:10-8:40am
		Keynote Lecture: Journey to FDA approved drugs in
Neurofibromatosis (REINS) - Andrea M. Gross

9:40-10:00am

BREAK

10:00-10:15am

BREAK

10:00-11:30am

Session II: von Hippel Lindau Syndrome

10:15-11:35am

Session II: Tuberous Sclerosis

10:00-10:30am

Keynote Lecture: TBD - Othon Iliopoulos

11:30-12:45pm

LUNCH Exhibit Hall AB

11:35-12:45pm

LUNCH Exhibit Hall AB

JOINT SESSION Moderators: Nicole J. Ullrich, Russell Lonser
Exhibit Hall C

12:45-2:30pm
		

AFTERNOON SESSION
Session III: Genetic Testing, Counseling and Clinical Implications

2:30-2:45pm

BREAK Exhibit Hall AB

BASIC SCIENCEAPPLIED SCIENCE

Exhibit Hall C

Ballroom A

2:45-4:40pm

Session IV: Neurofibromatosis

2:45-3:15pm
		Keynote Lecture: Mechanisms of Tumor Suppression by 		
Neurofibromatosis 2 Merlin - Andrea McClatchey

5:30-7:30pm

Independent Supported Sessions and Special Dinner Sessions - see pages 27-31

2:45-4:30pm

18 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Session IV: von Hippel Lindau Syndrome and Others

Friday, November 17, 2023 MAIN MEETINGCONCURRENT SESSIONSRoom 109-110

7:15-8:45am
		Room 121-122

Abstract Session: Clinical
Trials - Immunologic

Room 118-120

7:15-8:45am
		Ballroom B

Abstract Session:
Radiation Sciences

Ballroom C

7:15-8:45am
				

Abstract Session:
Molecular Pathology Computational

8:45-9:00am

BREAK Exhibit Hall AB

7:15-8:45am
		
		
		

7:15-8:45am
		Key Considerations for AYA
Patients and Programs

Ballroom A

ASNO-SNO Joint Session:
Updated Imaging
Phenotypes of CNS Tumors in
the Molecular and Genetic Era

7:15-8:45am
				Single Cell Biology: Tumor
Formation, Progression
and Treatment Response

PLENARY SESSION Co-Chairs: Shawn L. Hervey-Jumper, Michelle Monje, Humsa Venkatesh
Exhibit Hall C

9:00-9:05am

Welcome and Introduction

9:05-9:15am
		Top Scoring Abstract: Results of BMX-HGG study: a multi-institutional, randomized phase 2 clinical trial of concurrent chemoradiation with or without
BMX-001 in patients with newly diagnosed high grade glioma

9:15-9:25am

WiN Mentorship Award - Jaishri O. Blakeley

9:25-9:50am

Keynote Speaker: Pediatric Neuro-oncology - Mariella G. Filbin

9:50-10:15am

Sontag Distinguished Lecture and Keynote Presentation: Bridging Onco-Metabolism - Sriram Venneti

10:15-10:25am
		Top Scoring Abstract: Clinical activity and safety of the RAF inhibitor tovorafenib in patients with optic pathway gliomas in the registrational pediatriclow-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study

10:25-10:35am
		Top Scoring Abstract: Clinical activity of RAF inhibitor tovorafenib according to prior MAPK inhibitor treatment in the registrational pediatric low-grade
glioma arm of the phase 2 FIREFLY-1 (PNOC026) study

10:35-10:45am

BREAK Exhibit Hall AB

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 19

Friday, November 17, 2023 MAIN MEETINGCONCURRENT SESSIONSRoom 118-120

Room 109-110

10:45-12:15pm
		

Abstract Session:
Basic Science I

10:45-12:15pm
		

Room 121-122

Abstract Session:
Neurosurgery

Ballroom A

Ballroom C

10:45-12:15pm
				

10:45-12:15pm
		

Abstract Session:
Health Disparities

Ballroom B

Advanced Computationaland Diagnostic Imaging
Methods

10:45-12:15pm
				

Leptomeningeal
Metastasis from Basic
Science to Clinical Trials

12:15-12:45pm
12:45-1:45pm

LUNCH Exhibit Hall AB
Independent Supported Sessions and Special Lunch Sessions - see pages 27-31

1:45-2:00pm

BREAK Exhibit Hall AB

10:45-12:15pm
		

Pediatric CNS Tumors andCancer Predisposition

PLENARY II SESSION Co-Chairs: Shawn L. Hervey-Jumper, Michelle Monje, Humsa Venkatesh
Exhibit Hall C

2:00-2:30pm

Welcome and Keynote Speaker: Bridging Cancer and Neuroscience - Benjamin Deneen

2:30-2:40pm

Top Scoring Abstract: Targeting neuronal excitability for Nf1 low-grade glioma therapy

2:40-2:50pm

Jan Esenwein Public Service Award - Tara Mammoser

2:50-3:00pm

Top Scoring Abstract: Microglia repair the disrupted blood-brain barrier following low-intensity pulsed ultrasound through P2RY12 signaling

3:00-3:10pm
		

Top Scoring Abstract: Combining ONC201 and paxalisib for the treatment of diffuse midline glioma (DMG); the preclinical results underpinning theinternational Phase II clinical trial (NCT05009992)

3:10-3:20pm
		Top Scoring Abstract: A Pilot Study of Axicabtagene Ciloleucel (axi-cel) for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous
System Lymphoma (PCNSL and SCNSL)

3:20-3:30pm

Top Scoring Abstract: Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

20 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Friday, November 17, 2023 MAIN MEETING
3:30-3:45pm

BREAK Exhibit Hall AB

CONCURRENT SESSIONSRoom 118-120

3:45-5:15pm
		

Room 121-122

Abstract Session:
Basic Science II

3:45-5:15pm
		Ballroom C

3:45-5:15pm
		
		
		

Ballroom A

Abstract Session:
Pediatrics I

Room 109-110

The Integration ofTransformative Technology
in Spine Oncology: Who, What,
Where, When and Why

3:45-5:15pm
		

3:45-5:15pm
		

Biostatistics for Clinical
Trial Design

Ballroom B

Abstract Session: Clinical
Trials - Non-Immunologic

3:45-5:15pm
				

NeurologicalComplications of Cancer
Therapy

Exhibit C

3:45-5:15pm
		Rethinking Surgical
Strategies in the Modern Era

5:15-5:30pm

BREAK Exhibit Hall AB

5:30-7:30pm

Independent Supported Sessions and Special Dinner Sessions - see pages 27-31

RAPID REPORT SESSIONS
Zone 1
7:30-8:30pm

Zone 2
Session I

7:30-8:30pm

Zone 3Session II

7:30-8:30pm

Zone 4
Session III

7:30-8:30pm

Session IV

POSTER SESSION
7:30-9:30pm

Exhibit Hall AB

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 21

Saturday, November 18, 2023 MAIN MEETINGCONCURRENT SESSIONSRoom 109-110

7:15-8:45am
		Room 118-120

Abstract Session:
Basic Science III

7:15-8:45am
		Room 121-122

Abstract Session:
Cancer Neuroscience

Ballroom A

Ballroom B

7:15-8:45am
				

New Therapies in CNS
Hematologic
Malignancies

8:45-9:00am

BREAK Exhibit Hall AB

7:15-8:45am
				

7:15-8:45am
		Abstract Session:
Survivorship

Ballroom C

The Tumor
Microenvironment and
Immune Regulation

7:15-8:45am
		

PLENARY SESSION III Chairs: Shawn L. Hervey-Jumper, Michelle Monje, Humsa Venkatesh
Exhibit Hall C

9:00-9:05am

Welcome9:05-9:35am

Presidential Address - Tracy Batchelor

9:35-9:45am

Lifetime Achievement Award - Lisa DeAngelis

9:45-10:00am

SNO Excellence in Education Award, Honoring Lisa DeAngelis - Vinay K. Puduvalli

10:00-10:30am

Victor Levin Award & Lecture: Viruses and Genes in the Glioblastoma Immunooncology Frontier - Evanthia Galanis

10:30-10:45am

BREAK Exhibit Hall AB

22 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Treatment Response
Biomarkers

CONCURRENT SESSIONSRoom 109-110

10:45-12:15pm
		

Saturday, November 18, 2023 MAIN MEETING
Room 121-122

Abstract Session:
CNS Metastases

Room 118-120

10:45-12:15pm
		Exhibit Hall C

Abstract Session:
Neurology of Cancer

Ballroom A

Single Cell Biology,
GliomasBallroom C

10:45-12:15pm
				

Abstract Session:
Molecular Pathology Diagnosis

12:15-12:45pm
12:45-1:45pm

LUNCH Exhibit Hall AB
Independent Supported Sessions and Special Lunch Sessions - see pages 27-31

1:45-2:00pm

BREAK Exhibit Hall AB

10:45-12:15pm
				

10:45-12:15pm
		EANO/SNO Joint
Session: Focused
Ultrasound

10:45-12:15pm
				

Provider-Patient
Communication in the
Digital Age

PLENARY IV SESSION Chairs: Shawn L. Hervey-Jumper, Michelle Monje, Humsa Venkatesh
Exhibit Hall C

2:00-2:02pm

Welcome2:02-2:30pm

Quinn & Zeng Spinal Oncology Lecture: Multidisciplinary Clinical and Research Focus in Spine Oncology - Mark Bilsky

2:30-2:40pm

Top Scoring Abstract: For the love of work: Novel study of vocational cognitive rehabilitation in primary brain tumor

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 23

Saturday, November 18, 2023 MAIN MEETINGTOWN HALL: Debating Unanswered Questions in Neuro-Oncology Moderators: Shawn L. Hervey-Jumper, Humsa Venkatesh
Exhibit Hall C

2:40-2:45pm

Introduction

2:45-2:53pm
		Top Scoring Abstract: Impact of vorasidenib treatment on mutant IDH1 or IDH2 diffuse glioma tumor growth rate: results from the randomized,
double-blind, Phase 3 INDIGO study

2:53-3:01pm
		Top Scoring Abstract: A randomized double-blind Phase 3 study of vorasidenib vs placebo in patients with mutant IDH1/2 diffuse glioma (INDIGO): 		
exploratory analysis of variant allele frequency and progression-free survival

3:01-3:09pm
		Top Scoring Abstract: A randomized, double-blind Phase 3 study of vorasidenib vs placebo in patients with mutant IDH1/2 diffuse glioma (INDIGO): 		
analysis of health-related quality of life, neurocognition and seizures

3:09-3:30pm

Discussion and Q&A

3:30-3:45pm

BREAK Exhibit Hall AB

CONCURRENT SESSIONSRoom 109-110

3:45-5:15pm
		

Room 118-120

Abstract Session:
Basic Science IV

Ballroom A

3:45-5:15pm
		

Room 121-122

Abstract Session:
Neuroimaging Diagnosis

Ballroom C

Abstract Session:
Rare Tumors

Exhibit Hall C

3:45-5:15pm
		

Neurology ofBrain Cancer

5:30-7:30pm

Independent Supported Sessions and Special Dinner Sessions - see pages 27-31

7:30-10:30pm

SNO Gala Commodore Ballroom

3:45-5:15pm
				

3:45-5:15pm
		Pharmacokinetic-Driven
Clinical Trials in
Neuro-Oncology

24 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

3:45-5:15pm

RANO

Sunday, November 19, 2023 MAIN MEETINGCONCURRENT SESSIONSRoom 109-110

8:30-10:00am		Room 121-122

Abstract Session:
Basic Science V

8:30-10:00am		Ballroom C

Abstract Session:
Neuroimaging Prognosis

Ballroom B

Room 118-120

8:30-10:00am				

Abstract Session:
Molecular Pathology Classification

10:00-10:15am

BREAK Exhibit Hall AB

8:30-10:00am
		
		
		
		

8:30-10:00am				

New Drugs on the Market
for Pediatric LGG and
NF-Associated Neurofibroma

Advancing Therapies forPatients with Central
Nervous System Metastases:
From Basic Science toInnovative Clinical Trials

CONCURRENT SESSIONS
Ballroom B

Room 109-110
10:15-11:45am

Abstract Session: Basic Science VI

Immunotherapy for CNS Cancer

Ballroom A

Room 121-122
10:15-11:45am

10:15-11:45am

Abstract Session: Pediatrics II

10:15-11:45am

The Neuroscience of Glioma

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 25

Ancillary and SNO Committee Meetings		

Thursday, November 16, 2023

Friday, November 17, 2023

		
Room

Time		

7:00am-9:00pm
Tango Therapeutics Ad Board		
8:00am-1:00pm
Telix Advisory Board			
10:00am-11:00am WDC Leadership Program Meeting
12:00pm-1:00pm
SNO Board of Directors Meeting 		
1:00pm-4:00pm
Annual Symposium of the International
		Brain Tumor Immunology and		
Immunotherapy Interest Group		
1:00pm-5:30pm
GTN Group Meeting			
2:30pm-3:00pm
IOC Meet-N-Greet 			
3:00pm-5:00pm
Brain Tumor Nonprofit Leadership Meeting
5:00pm-7:00pm
DSA Reception			
5:00pm-7:30pm
Imvax Site Reception			
5:30pm-7:30pm
RANO Resect Group			
5:30pm-7:30pm
Ex Vivo/3D Predict Testing 					Friday, November 17, 2023 		

224
223
305
301
210

11:00am-11:30am External Relations Committee Meeting301
11:45am-12:15am Public Policy Committee Meeting301
12:45pm-2:00pm
BTCA Monthly Meeting		
216
1:15pm-1:45pm
Communications Committee Meeting301
5:00pm-6:00pm
RANO Radiotherapy Working Group215
5:00pm-7:00pm
Illumina Meeting (Tumor Classification)
210
5:00pm-7:30pm
Imvax KOL Reception			218-219
5:00pm-7:30pm
Servier Advisory Board		
224
5:30pm-7:30pm
MD Anderson Alumni Reception		
201
5:30pm-7:30pm
DFCI/MGH/BWH Neuro-Oncology
216		
Fellowship Reunion					
				Saturday, November 18, 2023
		Time		

Function				Room

6:30am-7:30am
7:00am-9:00am
		
7:00am-9:00am
8:00am-9:00am
8:00am-9:00am
		
8:30am-9:00am
9:00am-10:00am		
10:00am-11:00am		

Neuro-Oncology Advances Journal Meeting 220-222
Pivotal Trial Investigator Meeting for
224
SC9-GBM-03				
Biodexa Advisory Board		
210
Neuro-Oncology Practice Journal Meeting 220-222
Pediatric Fellowship Program 		301
Directors Meeting 				SNO/ASCO Leadership Meeting 		301
Career Development Training 		
301
Committee Meeting 					Adult Fellowship Match Program
301
Directors Meeting 					Time		

Function				215/216305
301
201
218-219
223
224

Function				

RoomTime		

Function				

7:00am-8:30am
7:00am-9:00am
10:00am-10:30am
		
10:45am-11:15am
12:15pm-1:45pm
12:30pm-2:00pm
		
5:00pm-7:00pm
5:00-7:00pm
5:30-7:30pm
5:30pm-7:30pm

Neuro-Oncology Journal Meeting220-222
Pathways Trial Kickoff			
215/216
Neuro-Oncology Academy Leadership
305
Meeting 					SNO Membership Meeting 		
305
SNO End-of-Year Committee Meeting
301
SNO NeuroHematology Working 		223
Group Meeting				Investigator Meeting			
201
JHU Reception			
210
ICOM Meeting 			220-222
Update Meeting			
215/216

26 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

RoomSpecial Events, Lunch and Dinner Sessions
Wednesday, November 15, 2023
Time		

Function											Room7:00am-6:30pm
7:30am-5:00pm
7:30am-5:00pm
12:00pm-5:15pm
5:00pm-7:30pm

8th Annual Neuro-Oncology Review Course								Clinical Trial Design Workshop Group 1 (Closed session)						Clinical Trial Design Workshop Group 2 (Closed session)						2023 Editorial Scholars Program In-Person Session (Closed session)					Scholars Reception (Closed session) 								Ballroom A
Ballroom B
121-122109-110Ballroom D

Thursday, November 16, 2023
Time		

		

Function											Room8:00am-4:30pm
5th Annual Neuro-Oncology Fellow and Early Clinician/Investigator Career Retreat				Ballroom B
11:35am-12:45pm Tumors Associated With Neurofibromatosis Type 1: Precision Medicine Approaches to Improve 			
211		
Patient Outcomes Across All Age Groups				Independent Supported Session - Supported by Clinical Care Options through a Medical Education Grant from		
Alexion Pharmaceuticals
11:45am-12:45pm SNOCares: Lessons in Resilience from a Brain Tumor Caregiver (Lunch will be provided) 				121-1222:00pm-5:20pm
Executive Leadership Program: Leading a Neuro-Oncology Program: What You Didn’t Know and Were Afraid to Ask
220-222
5:15pm-6:30pm
Shattering the Barriers to Glioblastoma Care: Revolutionary Advances With Innovative Technologies and 		
205-207		Modern Systemic Approaches		Independent Supported Session - This CME activity is provided by PVI, PeerView Institute for Medical Education.
		This activity has been developed in partnership with the American Brain Tumor Association.
		This activity is supported by an educational grant from Novocure, Inc. and Blue Earth Diagnostics.
5:30pm-6:30pm
Women and Diversity Award and Networking Reception				(New location) 118-120
6:30pm-7:30pm
Young Investigator’s Career Development and Networking Reception					Level 2 Ocean Foyer
7:30pm-10:00pm
SNO Welcome Reception (Pre-purchased ticket required)					Ballroom Foyer		28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 27

Special Events, Lunch and Dinner Sessions
Friday, November 17, 2023 		
Time		

Function											Room12:45pm-1:30pm
SNO Guidelines: Everything You Wanted to Know But Were Afraid to Ask (Lunch will be provided)			
301
12:45pm-1:45pm
Brain Tumor Network’s Commitment to Connection: An open dialogue on how patient navigation 			
211-212		
can support the patient, the caregiver and the neuro-oncology community
		Independent Supported Session - Supported by the Brain Tumor Network and The Sontag Foundation
12:45pm-1:45pm
Development of IGV-001 for the Treatment of Newly Diagnosed Glioblastoma				202-204
		Independent Supported Session - Supported by IMVAX					12:45pm-1:45pm
Sonodynamic Therapy: An Innovative Non-Invasive Neurosurgical Procedure for Brain Tumors			
205-207
		Independent Supported Session - Supported by SonALAsense								12:45pm-1:45pm
Tumor Treating Fields vs GBM – The Evidence and Experience						208-209
		Independent Supported Session - Supported by Novocure
12:45pm-2:00pm
Cultivating Diverse Leaders in the Society for Neuro-Oncology (Lunch will be provided)				
220-222
12:45pm-2:00pm
Modern Evolution of Neuro-Oncology Care in the Community (Lunch will be provided)				
121-1225:30pm-7:30pm
Student and Trainee Forum									220-2225:30pm-7:15pm
Towards Precision Neuro-Oncology: The Promise of PET Imaging with Amino 					
211		Acid Radiotracers for Brain Tumors				Independent Supported Session - Supported by Telix Pharmaceuticals
7:30pm-9:30pm
Rapid Reports and Poster Reception								Exhibit Hall AB
		28 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Special Events, Lunch and Dinner Sessions

Saturday, November 18, 2023
Time		

		

Function											12:45pm-1:45pm
Breaking Barriers: The Evidence for Hyperthermias Therapeutic Disruption of the Blood Brain 					Barrier and the Outlook on Immune Benefits in the Brain
		Independent Supported Session - Supported by Monteris Medical
12:45pm-1:45pm
H3 K27M-mutant Diffuse Glioma: Diagnosis to Treatment and Future Directions						Independent Supported Session - Supported by Chimerix, Inc.
12:45pm-1:45pm
Molecular Tumor Board: Case Studies Presentation									Independent Supported Session - Supported by Illumina
12:45pm-2:00pm
SNO Young Investigator Luncheon (Lunch will be provided)						12:45pm-2:00pm
Virtual Multidisciplinary Teams and Twinning Partnerships: Nuances and Practicalities in Neuro-Oncology		
5:30pm-7:30pm
Navigating New Therapeutic Options for IDH-Mutant Gliomas								Independent Supported Session - Supported by an independent educational grant from Servier
7:30pm-10:30pm
SNO Gala																								

Room208-209205-207202-204220-222121-122211-214
Commodore
Ballroom

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 29

Independent Supported Sessions
Thursday, November 16, 2023

Time		

Time		

12:45pm - 1:45pm Tumor Treating Fields vs GBM – The Evidence and Experience		
Room: 208-209
		Speakers: Coming soon.
		Registration: Coming soon.
		Supported by Novocure

Function					11:45am - 12:45pm Tumors Associated With Neurofibromatosis Type 1: Precision		Medicine Approaches to Improve Patient Outcomes Across All
		
Age Groups		
Room: 211
		Speakers: Jaishri Blakeley, Miriam Bornhorst, Michael J. Fisher
		Registration: www.clinicaloptions.com/NF1Vancouver2023
		Supported by Clinical Care Options through a Medical Education		Grant from Alexion Pharmaceuticals
5:15pm - 6:30pm
Shattering the Barriers to Glioblastoma Care: Revolutionary		Advances With Innovative Technologies and Modern Systemic		Approaches
		Room: 205-207
		Speakers: Steven Brem, Manmeet S. Ahluwalia, Michelle Kim
		Registration: PeerView.com/2023GBM-Live
This CME activity is provided by PVI, PeerView Institute for		Medical Education. This activity has been developed in		partnership with the American Brain Tumor Association. This		
activity is supported by educational grants from Blue Earth		Diagnostics and Novocure, Inc.

Friday, November 17, 2023
Time		

Function					12:45pm - 1:45pm Brain Tumor Network’s Commitment to Connection: An open		dialogue on how patient navigation can support the patient,		the caregiver and the neuro-oncology community		
Room: 211
		Speakers: Clark Chen, Courtney Burnett, Sharon Brown				Registration: Pre-register		
specialevents@braintumornetwork.org
		Supported by the Brain Tumor Network and The Sontag Foundation

Function					12:45pm - 1:45pm Development of IGV-001 for the Treatment of Newly		
Diagnosed Glioblastoma						
Room: 202-204
		Speakers: TBD
		Registration: TBD
		Supported by Imvax
12:45pm - 1:45pm Sonodynamic Therapy: An Innovative Non-Invasive		
Neurosurgical Procedure for Brain Tumors					
Room: 205-207
		Speakers: Ely Benaim, Kullervo Hynynen, Hasan Syed,		
Nader Sanai, Terrence Burns
		Registration: www.sonalasense.com/sno-registration
		Supported by SonALAsense
5:45pm - 7:15pm
Towards Precision Neuro-Oncology: The Promise of PET		Imaging with Amino Acid Radiotracers for Brain Tumors		
Room: 211-212
		Speakers: Nathalie Albert, Matthias Preusser
		Registration: https://bit.ly/46YvZGZ		Supported by Telix Pharmaceuticals

30 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-OncologyIndependent Supported Sessions

Saturday, November 18, 2023

Time		

Time		

12:45pm - 1:45pm Molecular Tumor Board: Case Studies Presentation				
Room: 202-204
		Speakers: Kenneth Aldape, Farshad Nassiri
		Registration: eventregistration.illumina.com/d/6pqyrm/4W
		Supported by Illumina

Function					12:45pm - 1:45pm H3 K27M-mutant Diffuse Glioma: Diagnosis to Treatment
		and Future Directions							Room: 205-207
		Speakers: Pieter Wesseling, Susan Short, Sriram Venneti,		Isabel Arrillaga-Romany
		Registration: TBD
		Supported by Chimerix, Inc.
12:45pm - 1:45pm Breaking Barriers: The Evidence for Hyperthermia’s		
Therapeutic Disruption of the Blood Brain Barrier and the		Outlook on Immune Benefits in the Brain		Room: 208-209
		Speakers: Jian Campian, Albert H. Kim, David Tran
		Registration: www.cognitoforms.com/
		Monteris1/_2023SNOIndependentSupportedSession
		Supported by Monteris Medical

Function		

5:45pm - 7:45pm
Navigating New Therapeutic Options for IDH-Mutant Gliomas
		
Room: 211-214
		
Speakers: Patrick Y. Wen, Elizabeth B. Claus,		
Macarena de la Fuente, Liz Salmi, Mehdi Touat,
		Martin J. van den Bent		
Registration: www.medscape.org/symposium/		
idh-mutant-glioma
		Supported by an independent educational grant from Servier

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 31

Exhibitors Map

32 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Exhibitors
Company				Booth Number

Company				Booth Number

Alexion Pharmaceuticals			
Alexion Pharmaceuticals Medical Affairs 		
American Brain Tumor Association		
Brain Tumor Foundation of Canada		Brain Tumor Network			CARIS Life Sciences				
ChadTough Defeat DIPG Foundation		
Children’s Tumor Foundation			
Chimerix Inc.				
Cortech.ai					Day One					ECD Global Alliance				End Brain Cancer Initiative			European Association of Neuro-Oncology (EANO)
Focused Ultrasound Foundation			GT Medical Technologies/GammaTile		
Head for the Cure				
Houston CVB				Imvax					International Brain Tumour Alliance		
Ivy Brain Tumor Center			Kiyatec					Lunaphore Technologies			
MedaSystems, Inc.				
Medidata Solutions, Inc.			
Medtronic					Merck					400/402
301/303204/206
109
307
406
512
408
500/401103
101/200
404
209
300
213
405
504
SNO Central
413
105
203
215/217
506
310
510
201
208

Monteris Medical				
MRI Math LLC				National Brain Tumor Society			
Neuro-Oncology Academy			
NICO Corporation				
Northwest Biotherapeutics			
Novocure					Orbus Therapeutics				
OurBrainBank				Oxford University Press			
Pediatric Brain Tumor Foundation		
Plus Therapeutics				Renishaw NeuroSolutions			
Seagen					Servier					SNO Wellness Committee			
SonALAsense				SpringWorks				Telix					The Brain Tumour Charity			
The Sontag Foundation			
University of Florida Neuroscience		UW Medicine Neurosciences Institute 		& Alvord Brain Tumor Center
Zap Surgical				ZEISS					

211
304409/411
SNO Central
107
214
313
309
306
SNO Central
403
407
502
202
415/417/514/516
SNO Central
205/207
210
316
508
305
111
302
311
312

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 33

1. Download the SN

Scan thisScientifi
APP NAME: SNO SCIENTIFIC MEETINGS
or Google
SELECT: SNO 2023 ANNUAL MEETING
INSTALL
App supported by Novocure
the event
Make the Most of Your Conference Experience with the
CLICK thNotetaking
Create Annual& Share Schedules
I Searchable
Abstracts
2023I SNO
Meeting
MobileApp!I Social Features I Networking
MEETING APP*Download before you go! O

Notetaking | Create & Share Schedules | Searchable Abstracts | Social Features | Networking

1. Download the SNO App*
Scan this QR Code or search for SNO
Scientific Meetings in the Apple App Storeor Google Play Store.
INSTALL and OPEN the app then SELECT
the event: SNO 2023 Annual Meeting
34 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
CLICK the icon to launch your app.

2. LogDOWNLOAD
in to the App

THE MEETING
Select"Login"to procee
MOBILEAPP!

App Icon

You will be asked to ent

A

EXHIBITION LEVEL

WEST LEVEL 3

EX
B1
HA

B2

WEST LEVEL 2
VANCOUVER HARBOUR FLIGHT CENTRE(FLOAT
WESTPLANELEVELTERMINAL)
1

BURRARD INLET

B3
C

WEST
EXHIBITION LEVEL

A&
A
A&
B
A&
B1
B1

LOADING BAYSTRUCK
TURNAROUND
EAST BUILDINGRAMP A

RAMP B

RAMP C

B2
B2
C&
B3
C&
C
B&

BURRARD INLETVANCOUVER HARBOUR FLIGHT CENTRE(FLOAT PLANE TERMINAL)
OVERHEAD DOOR
22’6” (6.85 m) w
x 15’4” (4.67 m) h

HALL CSHOW
OFFICE

TRUCK
TURNAROUND

B

Exhibition Level

EAST BUILDINGHALL BSHOW
OFFICELOADING BAYS

OVERHEAD DOOR
22’6” (6.85 m) w
x 15’4” (4.67 m) h

HALL ASHOW
OFFICEFREIGHTELEVATORS

A
A&
&
A&

SERVICEELEVATORSOTOVERHEAD DOOR
16’4” (4.98 m) w x 15’4“” (4.67 m) h
FORKLIFT ONLY

OVERHEAD DOOR
22’6” (6.85 m) w
x 15’4” (4.67 m) h

HALL CSHOW
OFFICEOVERHEAD DOOR

16’4” (4.98m) w x 15’4“” (4.67 m) h
EXHIBITIONHALLFORKLIFT ONLYC

HALL BSHOW
OFFICE

HALL ASHOW
OFFICE

* Cap
C&
Ban
**CTh
&
Pl
B C&
***

OVERHEAD DOOR
22’6” (6.85 m) w
x 15’4” (4.67 m) h
FREIGHTELEVATORSEXHIBITION HALL

EXHIBITION HALL

72,000 ft 2
6,689 m 2

58,502 ft 2
5,435 m2

C

B3

18,000 ft 2
1,672 m 2

90,000 ft 2
8,361 m 2

OT

Exh
Foy

* Cap
Ban
** Th
Ple
*** C

SERVICEELEVATOREXHIBITION HALLA&SERVICEELEVATORSBACK OF HOUSE

A

B

90,000 ft 2
8,361 m 2

A&
Exh
B1
Foy
B2

RAMP A

RAMP B

RAMP C

B2
B

B1

EXHIBITION 2HALL
27,000 ft
2,508 m 2

27,000 ft 2
2,508 m 2

72,000 ft 2
6,689 m 2

EXHIBITION HALL

TRUCK
ROUTE

NORTH

TRUCK
ROUTE

NORTH

BACK OF HOUSE

A

58,502 ft 2
5,435 m2

OVERHEAD DOOR
22’6” (6.85 m) w x 23’11” (7.11 m) h

EXHIBITION HALL FOYER
REGISTRATION SUPPORTTO/FROMLEVEL 1

B3

18,000 ft 2
1,672 m 2

OVERHEAD DOOR
22’6” (6.85 m) w x 23’11” (7.11 m) h

TO/FROMLEVEL 1B2SERVICEELEVATOR

B1

27,000 ft 2
2,508 m 2

27,000 ft 2
2,508 m 2

WATERFRONT ROAD

28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 35

EXHIBITION HALL FOYER
REGISTRATION SUPPORTTO/FROM

TO/FROM

Level 1

A
B

WEST LEVEL 3

C

WEST LEVEL 2D

BURRARD INLETA

WEST LEVEL 1

LEVEL 1 OCEAN FOYER

EAST BUILDING120

BALLROOM

7,980 ft 2
741 m2

D

122

DIGITAL ORCA
(ART PIECE)

119

LEVEL 1BURRARD TERRACE

A&

WEST
EXHIBITION LEVELTHE DROP(ART PIECE)

B

B&

C

A&

M

121

10

10

118

10
TO/FROMLEVEL 2BACK OFHOUSEC

JACK POOLE
PLAZA

10

10

BALLROOMBACK OF HOUSE

15,120 ft 2
1,405 m 2

10
FREIGHTELEVATORSSERVICEELEVATORS

1010WEST PACIFICTERRACE

10

114

CORRIDOR SPACE AVAILABLE WHEN ROOMS COMBINED

115

116

10

117

10
SEAWALL
PATHWAY

KITCHENBALLROOM
FOYER

10

10

BALLROOM

15,120 ft 2
1,405 m 2

B

110

113

112

10

111

111

112

111

110
BALLROOM

14,448 ft 2
1,342 m2

A

TO/FROMLEVEL 2

113

LEVEL 1BURRARD
FOYER

114

115

109

114

GRAND
STAIRCASE

116

117

THURLOW STREETENTRANCE

LOT 185
CAFÉ +
WINE BARSHOW OFFICE

FIRST
AID

101

102

103

104

105

106

107

116

SERVICEELEVATOR

108

NORTH

118

119

12

119
LEVEL 1
CITY FOYERENTRANCE
LOBBY

36 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
RAMP

BC BUSINESSLAUREATESHALL OF FAMEACCESS TO RETAILON BURRARD LANDING
TO/FROMLEVEL 2ACCESS TO
PARKADE /

118

12

12
TO /

12

Level 2

ME
RO

WEST LEVEL 3

BURRARD INLET

WEST LEVEL 2
WEST LEVEL 1

LEVEL 2 OCEAN FOYER

WEST
EXHIBITION LEVEL

20

20

TO/FROMLEVEL 1LEVEL 2 OCEAN TERRACEEAST BUILDING

222

224

20

20

221

20

223

20

20

220

BACK OF HOUSE

20
TO/FROMLEVEL 320

20

20
FREIGHTELEVATORS20SERVICEELEVATORS

20

20

20

215

216
216

217
217

218

20

219

210

ABOVE BALLROOMS

211

212

213

214

213

212

OPEN TOBALLROOM FOYER214

LEVEL 2BURRARD
FOYER

212

213

212

211

215

211
211

216

215

217

GRAND
STAIRCASE

218

LIVING ROOF

219

TO/FROMLEVEL 1SERVICEELEVATOR

201
201

209
209
202
202

203
203

204
204

205
205

206

207
208

210

NORTH

TO/FROMLEVEL 1

217

22

22
TO/FROMLEVEL 128 Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology I 37
TH

218

22

LEVEL 2CITY FOYER
WORKSPRING AREA

LIVING ROOF

217

22

22

22

JOIN SNO NEXTYEAR IN
HOUSTON!

29 T H A N N U A L M E E T I N G and E D U C AT I O N D AY
OF THE SOCIETY FOR NEURO-ONCOLOGYHOUSTON, TEXAS • NOVEMBER 21-24, 2024
38 I 28TH Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

The Society for Neuro-Oncology gratefully acknowledges the SNO Platinum Partners listed below.
Their on-going support allows SNO to fulfill its mission to advance neuro-oncology research and education.

PLATINUM LEVEL

NASDAQ: NWBO | NWbio.com | info@nwbio.com

DC
VAX
TECHNOLOGY®

Personalized Immune Therapies

SERVIER
SER_21_00001_Logo_Sign_RVB
JFB

94 avenue Gambetta - 75020 PARIS+33 (0)1 85 56 97 00 www.carrenoir.com

Date : 19/07/2021

Ce fichier est un documentd’exécution créé sur Illustrator
version CS6.

The Society for Neuro-Oncology wishes to express appreciation to the organizations listed
below for their promotional support of this meeting.

BENEFACTOR LEVELSUPPORTER LEVELCONTRIBUTOR LEVEL

GENERAL LEVEL